Metabolomics Creative Proteomics
Submit Your Inquiry

Heparan Sulfate & Heparin LC-MS/MS Quantification Service

Heparan sulfate (HS) and heparin are structurally intricate glycosaminoglycans that regulate blood coagulation, lysosomal storage, and cell signaling. However, their biological functions hinge on fine disaccharide structures and sulfation motifs—requiring more than generic carbohydrate assays.

At Creative Proteomics, we deliver precise, quantitative LC-MS/MS-based HS/heparin profiling that deciphers sulfation patterns, disaccharide composition, and chain length-empowering your drug development, glycomics, or MPS research with structurally grounded data.

What You Gain with Our Service:

  • Disaccharide-level profiling of HS and heparin
  • Mapping of N-, 2-O-, 6-O-, and 3-O-sulfation
  • Total GAG quantification with isotope-labeled calibrants
  • Full MS workflow with QC, calibration, and reporting
  • Expert support for GAG, glycomics, and ECM projects
CONTACT EXPERT
  • Service Details
  • FAQ
  • Publications
  • Submit Your Inquiry

Why Analyze Heparan Sulfate and Heparin?

Heparan sulfate (HS) and heparin are structurally diverse glycosaminoglycans (GAGs) that play essential roles in biological signaling, extracellular matrix integrity, and disease progression. Their functions are not dictated by a single sequence but by subtle differences in disaccharide composition, sulfation motifs, and chain length distribution.

These complex features govern interactions with growth factors, cytokines, and enzymes—making HS/heparin pivotal in coagulation regulation, lysosomal storage disorders (MPS), tumor progression, and host–pathogen interactions. Yet, conventional glycan detection methods often fail to resolve these fine structural determinants, leaving gaps in interpretation and comparability across samples.

At Creative Proteomics, we address this analytical challenge by offering quantitative, disaccharide-resolved LC–MS/MS-based HS/heparin profiling. Our platform allows researchers to:

  • Accurately characterize N-, 2-O-, 6-O-, and 3-O-sulfation patterns
  • Quantify total HS/heparin levels in serum, tissue, urine, and bioprocess samples
  • Compare structural fingerprints across models, conditions, or drug lots

Whether you're working on MPS biomarkers, heparin product QC, or ECM remodeling, our GAG-targeted workflows provide actionable molecular resolution—turning structural complexity into scientific clarity.

What We Measure: Quantitative HS/Heparin Profiling

Our service delivers quantitative profiling of heparan sulfate and heparin directly from biological samples including serum, plasma, urine, tissues, cells, and feces. Beyond measuring total content, we resolve key structural and compositional features that govern their biological functions.

Total HS/Heparin Levels

We determine the absolute concentration of HS and/or heparin in each sample (e.g., ng/mL or μg/mg tissue). This global metric is ideal for:

  • Monitoring GAG accumulation in metabolic or inflammatory models
  • Comparing total GAG burden across conditions or treatment groups
  • Supporting research on ECM remodeling or lysosomal storage disorders (RUO)

Disaccharide Composition Analysis

Following enzymatic digestion, HS/heparin chains are converted to discrete disaccharide units, which we quantify using LC–MS/MS with isotope-labeled internal standards. This enables:

  • Molar and mass-based quantification of individual disaccharides
  • Detection of domain shifts (e.g., NS- vs. NA-regions)
  • Generation of sample-specific structural fingerprints

Sulfation Pattern and Epimerization Metrics

Biological specificity resides in where and how GAG chains are sulfated. We calculate:

  • N-sulfation vs. N-acetylation ratios
  • 2-O-, 6-O-, and 3-O-sulfation motif distribution
  • Indicators of C5-epimerase activity (GlcA ↔ IdoA)

These readouts are essential for understanding pathway regulation, enzyme activity, and structural consistency in therapeutic applications.

Chain Length Distribution and GAG Panel Integration

For advanced projects, we can provide:

  • Chain-length and polydispersity analysis (via GPC–MS or CE–MS)
  • Cross-panel profiling of other GAGs (e.g., CS, DS, KS) or key glycan precursors (e.g., UDP-GlcNAc, PAPS)

This expanded scope supports integrative GAG metabolism studies within your broader omics pipeline.

Analytes Covered in the Heparan Sulfate/Heparin Panel

Category Analyte / Metric Description / Purpose
Total Content Total Heparan Sulfate (HS) Global GAG burden across samples (e.g., ng/mL)
Total Heparin (if applicable) Relevant for drug consistency or degradation studies
Disaccharide Species 
(LC–MS/MS)
ΔUA–GlcNAc (0S) Unsulfated unit – baseline marker
ΔUA–GlcNS (NS) N-sulfated domain indicator
ΔUA–GlcNAc(6S) (6S) 6-O-sulfation motif
ΔUA–GlcNS(6S) (NS6S) Dual N-/6-O-sulfation
ΔUA(2S)–GlcNAc (2S) 2-O-sulfation site
ΔUA(2S)–GlcNS (NS2S) High-sulfated domain marker
ΔUA–GlcNS(3S)* (NS3S) Rare 3-O-sulfated epitope
ΔUA(2S)–GlcNS(6S) (TriS) Fully sulfated disaccharide
Structural Indices 
(Derived Metrics)
NS/NA ratio Domain composition indicator
Sulfate groups per disaccharide Average sulfation density
2-O / 6-O / 3-O sulfation ratio Sulfation position balance
GlcA / IdoA ratio Epimerization marker
Chain length & polydispersity* Optional via GPC–MS / CE–MS
Optional GAG Extensions CS/DS disaccharides Chondroitin / dermatan sulfate profiling
Keratan sulfate fragments Matrix remodeling context
UDP-GlcNAc, PAPS GAG biosynthesis precursors

*Note: Some analytes are optional or matrix-dependent. TriS and 3-O-sulfation markers may require enhanced sensitivity.

Advantages of Our HS/Heparin Analysis Service

  • Absolute Quantification with Internal Standards
    Isotope-labeled calibrants ensure accurate disaccharide-level measurement (R² ≥ 0.995, CV ≤ 10%).
  • Disaccharide-Level Resolution
    Profile ≥8 HS/heparin disaccharides, including mono-, di-, and tri-sulfated motifs.
  • Detailed Sulfation Pattern Analysis
    Distinguish N-, 2-O-, 6-O-, and optional 3-O-sulfation for structural interpretation.
  • Compatible with Real Biological Matrices
    Validated for serum, plasma, urine, tissue, and cell samples—no purification required.
  • Optional Chain-Length Profiling
    Assess molecular weight and polydispersity via GPC–MS or CE–MS.
  • Comprehensive QC and Publication-Ready Data
    Receive raw files, quantitative tables, calibration curves, and recovery reports.
  • Multi-GAG Expansion Available
    Add CS, DS, KS disaccharides or precursors like UDP-GlcNAc, all in one project.

Analytical Platforms and Technical Specifications for HS/Heparin Analysis

Our HS/heparin panel runs on a validated targeted metabolomics workflow with high-sensitivity LC–MS/MS at its core. The parameters below outline the data quality and reproducibility you can expect.

Analytical Platforms

Platform Main Models (Typical) Primary Use
LC–MS/MS Thermo Q Exactive™ HF-X
Sciex Triple Quad™ 6500+
Disaccharide identification and quantitative profiling
Optional GPC–MS / CE–MS (on request) Chain-length distribution and sulfation isomer resolution

Quantitative Method Highlights

Parameter Specification (Typical)
Acquisition mode MRM (triple quad) and/or Full MS ± MS/MS (Orbitrap)
Calibration strategy 13C/15N-labeled HS/heparin disaccharide internal standards
Calibration linearity R² ≥ 0.995 across the validated range
Intra-assay precision (CV) ≤ 10% for most disaccharides
Sensitivity (LOD/LOQ) Low ng/mL range, matrix-dependent
Reporting Absolute and relative concentrations, derived structural indices

Quality Control

  • Batch-specific blanks, calibration standards, and QC samples included
  • Continuous monitoring of internal standard recovery and retention time stability
  • Review of peak shape and integration for each reported disaccharide
Thermo Q Exactive HF-X MS

Q Exactive HF-X MS Figure from Thermo)

SCIEX Triple Quad™ 6500+

Triple Quad™ 6500+ (Figure from Sciex)

Step-by-Step Workflow for HS/Heparin LC–MS/MS Analysis

1

Project Scoping

Define research goals, sample types, and required depth (total HS only vs full disaccharide/sulfation ± size distribution).

2

Sample Receipt & Check

Log samples, verify volume/matrix/storage, and ensure conditions are suitable for HS/heparin stability.

3

Extraction & Enzymatic Digestion

Enrich HS/heparin from the matrix and digest into defined disaccharides, adding isotope-labeled standards to track recovery.

4

Instrumental Analysis

Perform LC–MS/MS for quantitative disaccharide profiling; optionally add GPC–MS or CE–MS for chain length and isomer resolution.

5

Data Processing & QC

Process spectra to obtain total HS/heparin, disaccharide levels, and structural indices, releasing only QC-approved results.

6

Reporting & Follow-Up

Deliver raw data, result tables, QC summary, and key plots, with optional consultation on data interpretation in your metabolomics context.

Polyphenol Targeted Analysis Workflow

How to Submit Samples for HS/Heparin LC–MS/MS Analysis

Sample Type Minimum Amount Container / Handling Notes
Serum / Plasma ≥ 500 μL Collect, centrifuge, aliquot clear supernatant; store at −80 °C. Avoid repeated freeze–thaw.
Anticoagulated Blood (EDTA) ≥ 1 mL Mix gently with anticoagulant, aliquot, freeze at −80 °C as soon as possible.
Urine ≥ 1 mL Collect midstream if possible, aliquot, add preservative if required, store at −80 °C.
Tissue (animal or human research samples) ≥ 200 mg Snap-freeze in liquid nitrogen after collection; store at −80 °C in pre-labeled tubes.
Cells (adherent or suspension) ≥ 1 × 10⁷ cells Wash to remove medium, pellet, remove supernatant, freeze pellets at −80 °C.
Feces ≥ 500 mg Collect into sterile tubes, avoid cross-contamination, freeze at −80 °C.

General Handling Guidelines

  • Use pre-chilled tubes where possible and minimize time at room temperature.
  • Avoid repeated freeze–thaw cycles; prepare multiple small aliquots instead of one large vial.
  • Clearly record matrix, species, treatment groups, collection time points, and any stabilizers or anticoagulants used.
  • Ship samples on dry ice with sufficient coolant to maintain frozen conditions until arrival.

What You Receive: HS/Heparin Analysis Deliverables

Raw data files: LC–MS/MS instrument files (and GPC–MS/CE–MS, if included in the project), provided in native or agreed converted formats.

Quantitative result tables: Spreadsheet with per-sample results, including total HS/heparin levels, quantified disaccharides, and any agreed structural indices (e.g., NS/NA ratio, sulfation pattern metrics).

QC summary: Bief overview of calibration performance (e.g., linearity), internal standard recovery, and repeatability (CV) to support data reliability assessment.

Method summary: Short description of sample preparation, enzymatic digestion, analytical platform, and data processing workflow, suitable for use in internal reports or manuscript Methods

LC–MS/MS EIC separation of heparan sulfate disaccharides with representative MS/MS spectra for structural confirmation

LC–MS/MS separation and identification of HS/heparin disaccharides.

Calibration curve and LOD plot demonstrating quantitative linearity and sensitivity for a representative heparan sulfate disaccharide

Calibration and sensitivity for a representative HS disaccharide.

Use Cases of Heparan Sulfate/Heparin Quantification

GAG accumulation studies in metabolic disorders

Measure HS disaccharides in plasma, urine, or DBS for understanding glycosaminoglycan buildup in genetic models.

Vascular integrity and endothelial biology

Track HS fragments to study glycocalyx shedding under oxidative stress, inflammation, or mechanical injury.

Cancer biology and microenvironment research

Investigate HS structural patterns linked to ECM remodeling, angiogenic signaling, and cell–matrix interactions.

Growth factor signaling and regeneration pathways

Profile sulfation motifs that regulate FGF, VEGF, and Wnt activity during tissue repair or stem cell culture.

Neurobiology and glycan clearance mechanisms

Explore HS degradation and turnover in CNS tissue models of aging or neurodevelopment.

GAG product research and structural comparability

Compare the disaccharide composition and sulfation domains in natural vs. synthetic HS/heparin materials.

HS mimetic and GAG-targeted agent development

Support studies evaluating synthetic HS analogs used in bioengineering or ligand-binding modulation.

Embryonic development and morphogen modulation

Analyze HS profiles affecting morphogen gradients such as Hedgehog, BMP, and Wnt in model organisms.

What makes HS/heparin more difficult to analyze than other glycans?

HS/heparin contains highly heterogeneous sulfation patterns, variable epimerization and domain structures that cannot be inferred from bulk composition; resolving these requires specific enzymatic digestion, stable-isotope calibration and high-resolution MS to avoid losing positional information or underestimating minor sulfation motifs.

Why compare disaccharide fingerprints instead of relying on one summary metric?

Different biological states often shift sulfation motifs or domain structures without changing the overall amount of HS/heparin, so a fingerprint enables you to see functional structural remodeling that a single total-GAG measurement would completely miss.

Can this analysis differentiate subtle structural variations across treatments or batches?

Yes; disaccharide-level quantification amplifies fine differences in sulfation and epimerization patterns, allowing you to distinguish near-neighbor samples that would otherwise appear identical when only total HS/heparin is measured.

How do researchers typically interpret changes in specific disaccharides?

Shifts toward higher N-sulfation, 2-O or 6-O motifs usually indicate pathway activation or altered modification enzyme activity, whereas reduced sulfation often signals remodeling, enzymatic inhibition or processing differences; patterns are read as coordinated structural signatures rather than isolated analytes.

Does sample matrix affect which disaccharides can be confidently quantified?

Matrix composition can suppress ionization or enrich certain motifs, but using isotope-labeled internal standards normalizes these effects so most disaccharides remain quantifiable across diverse matrices such as serum, urine, tissues or cell extracts.

What additional insights come from integrating other GAGs or biosynthetic precursors?

Adding CS/DS/KS disaccharides or precursors like UDP-GlcNAc helps reveal whether structural changes in HS/heparin are isolated or part of broader GAG pathway shifts, enabling pathway-level interpretation rather than treating HS/heparin changes in isolation.

Why might two samples with similar abundance differ in functional interpretation?

HS/heparin function is encoded by position-specific sulfation and domain architecture; two samples can contain the same overall amount but differ in motifs that govern interactions with proteins, so structural resolution is essential for any functional inference.

Is chain-length information useful if disaccharides are already quantified?

Yes; chain length reflects polymer processing and modification enzyme activity, providing orthogonal insight that disaccharides alone cannot capture, especially when evaluating structural consistency, process-related changes or multi-parameter GAG remodeling.

The Brain Metabolome Is Modified by Obesity in a Sex-Dependent Manner

Norman, J. E., Milenkovic, D., Nuthikattu, S., & Villablanca, A. C.

Journal: International Journal of Molecular Sciences

Year: 2024

Sex modifies the impact of type 2 diabetes mellitus on the murine whole brain metabolome

Norman, J. E., Nuthikattu, S., Milenkovic, D., & Villablanca, A. C.

Journal: Metabolites

Year: 2023

Quantifying forms and functions of intestinal bile acid pools in mice

Sudo, K., Delmas-Eliason, A., Soucy, S., Barrack, K. E., Liu, J., Balasubramanian, A., ... & Sundrud, M. S.

Journal: bioRxiv

Year: 2024

Untargeted metabolomics reveal sex-specific and non-specific redox-modulating metabolites in kidneys following binge drinking

Rafferty, D., de Carvalho, L. M., Sutter, M., Heneghan, K., Nelson, V., Leitner, M., ... & Puthanveetil, P.

Journal: Redox Experimental Medicine

Year: 2023

Metabolomic Studies in Girls With Central and Peripheral Precocious Puberty

Özyurt, A. B., Reçber, T., Nemutlu, E., Buluş, D., Kır, S., Gümüşel, B. K., & Erkekoğlu, P.

Journal: Fabad Journal of Pharmaceutical Sciences

Year: 2023

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top